Predominance of international clone 2 OXA-23-producing- Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study

Visca, 2011, Acinetobacter infection—an emerging threat to human health, IUBMB Life, 63, 1048, 10.1002/iub.534 European Centre for Disease Prevention and Control Flamm, 2016, Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013), Diagn Microbiol Infect Dis, 85, 352, 10.1016/j.diagmicrobio.2016.03.019 Fishbain, 2010, Treatment of Acinetobacter infections, Clin Infect Dis, 51, 79, 10.1086/653120 Zarrilli, 2013, Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages, Int J Antimicrob Agents, 41, 11, 10.1016/j.ijantimicag.2012.09.008 Gogou, 2011, Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000–09), J Antimicrob Chemother, 66, 2767, 10.1093/jac/dkr390 D'Arezzo, 2011, Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy, J Antimicrob Chemother, 66, 54, 10.1093/jac/dkq407 Djahmi, 2014, Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries, Biomed Res Int, 2014, 305784, 10.1155/2014/305784 Liakopoulos, 2012, Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011, Euro Surveill, 17, 10.2807/ese.17.11.20117-en Turton, 2006, Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species, J Clin Microbiol, 44, 2974, 10.1128/JCM.01021-06 Clinical and Laboratory Standards Institute, 2015 Magiorakos, 2012, Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance, Clin Microbiol Infect, 18, 268, 10.1111/j.1469-0691.2011.03570.x Woodford, 2006, Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp, Int J Antimicrob Agents, 27, 351, 10.1016/j.ijantimicag.2006.01.004 Higgins, 2010, Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp, Int J Antimicrob Agents, 35, 305, 10.1016/j.ijantimicag.2009.10.014 Poirel, 2011, Multiplex PCR for detection of acquired carbapenemase genes, Diagn Microbiol Infect Dis, 70, 119, 10.1016/j.diagmicrobio.2010.12.002 Turton, 2006, The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii, FEMS Microbiol Lett, 258, 72, 10.1111/j.1574-6968.2006.00195.x Turton, 2007, Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii, Clin Microbiol Infect, 13, 807, 10.1111/j.1469-0691.2007.01759.x Giannouli, 2010, Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone, J Clin Microbiol, 48, 1223, 10.1128/JCM.02263-09 Pournaras, 2014, Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages, J Clin Microbiol, 52, 1653, 10.1128/JCM.03565-13 Sahl, 2015, Phylogenetic and genomic diversity in isolates from the globally distributed Acinetobacter baumannii ST25 lineage, Sci Rep, 5, 15188, 10.1038/srep15188 Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing, J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995 Lob, 2016, Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii, Int J Antimicrob Agents, 47, 317, 10.1016/j.ijantimicag.2016.01.015 Mugnier, 2010, Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii, Emerg Infect Dis, 16, 35, 10.3201/eid1601.090852 Schleicher, 2013, Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009), Clin Microbiol Infect, 19, 737, 10.1111/1469-0691.12026 Karah, 2012, Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii, Drug Resist Updat, 15, 237, 10.1016/j.drup.2012.06.001 Viehman, 2014, Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections, Drugs, 74, 1315, 10.1007/s40265-014-0267-8